Brazil resumes CoronaVac trial after pause over 'adverse event'
Brazilian trials of the CoronaVac vaccine will resume, after testing was temporarily stopped due to a "serious adverse event" in one of the volunteers.
Brazilian trials of the CoronaVac vaccine will resume, after testing was temporarily stopped due to a "serious adverse event" in one of the volunteers.